1239--9--3-[2--1--1-]-4--4- PROCESS FOR THE PREPARATION OF 1239-TETRAHYDRO-9-METHYL-3-[2-METHYL-1H-IMIDAZOL-1-YLMETHYL]-4H-CARBAZOL-4-ONE OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF

PURPOSE: Provided is a novel manufacturing method of 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1H-imidazol-1-yl))-4H-carbazol-4-on or its pharmaceutically acceptable salt in higher yield and purity than conventional methods. CONSTITUTION: The manufacturing method is characterized by reacting 1,2,3,9-...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: LEE, GWANG OK, JUNG, GEUM SIN, KIM, GI EUN, LEE, HOE CHEOL, KIM, MAENG SEOP, LEE, GWAN SUN, KIM, HUI SEOK, HAM, YEONG JIN, KIM, CHEOL GYEONG, KIM, HAN GYEONG
Format: Patent
Sprache:eng ; kor
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator LEE, GWANG OK
JUNG, GEUM SIN
KIM, GI EUN
LEE, HOE CHEOL
KIM, MAENG SEOP
LEE, GWAN SUN
KIM, HUI SEOK
HAM, YEONG JIN
KIM, CHEOL GYEONG
KIM, HAN GYEONG
description PURPOSE: Provided is a novel manufacturing method of 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1H-imidazol-1-yl))-4H-carbazol-4-on or its pharmaceutically acceptable salt in higher yield and purity than conventional methods. CONSTITUTION: The manufacturing method is characterized by reacting 1,2,3,9-tetrahydro-9-methyl-4H-carbazol-4-on of the formula(2) with 2-methylimidazole derivative of the formula(3) in a mixed solvent of organic solvent and water at room temperature to 150 deg.C fro 2-12 hours to manufacture 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1H-imidazol-1-yl))-4H-carbazol-4-on of the formula(1) or its pharmaceutically acceptable salt. 본 발명은 할로실란 화합물 존재하에서 하기 화학식 2의 1,2,3,9-테트라히드로-9-메틸-4H-카바졸-4-온을 화학식 3의 2-메틸이미다졸 유도체와 유기용매 또는 유기용매와 물의 혼합용매 중에서 반응시키는 것을 특징으로 하는, 화학식 1의 1,2,3,9-테트라히드로-9-메틸-3-[(2-메틸-1H-이미다졸-1-일)메틸]-4H-카바졸-4-온 또는 그의 약제학적으로 허용가능한 염의 제조 방법에 관한 것으로, 본 발명의 방법에 따르면 보다 간단한 공정으로 목적 화합물을 고수율, 고순도로 제조할 수 있다. 상기 식에서, R은 N,N-디메틸아미노, N,N-디에틸아미노, N,N-디프로필아미노, 몰포린-4-일, 피페리딘-1-일 또는 피롤리딘-1-일이다.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_KR20020039223A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>KR20020039223A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_KR20020039223A3</originalsourceid><addsrcrecordid>eNqNjk0KwkAMhbtxIeodBlwH7Iwbl3GaMsWpU9K4qCJSZFyJCno2z-f4cwDhg7yE5L0Ms2euzQIgYWCnAfI3e5hDQjUcLLWtKgMrcZR6apBRqrBWoVSfUyFhdF3BIZnUJK7zX6ufzh1UdVXgNiQNnf-OU4IDi7z8zOcQ1qRSSOOQa7S0kcqi951Ca6kRXHpSLXpp328whXKcDU79-R4nvzrKpiWJdRBv10O83_pjvMTHYcV6NkuYhdYGzX9bL1VGSTA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>1239--9--3-[2--1--1-]-4--4- PROCESS FOR THE PREPARATION OF 1239-TETRAHYDRO-9-METHYL-3-[2-METHYL-1H-IMIDAZOL-1-YLMETHYL]-4H-CARBAZOL-4-ONE OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF</title><source>esp@cenet</source><creator>LEE, GWANG OK ; JUNG, GEUM SIN ; KIM, GI EUN ; LEE, HOE CHEOL ; KIM, MAENG SEOP ; LEE, GWAN SUN ; KIM, HUI SEOK ; HAM, YEONG JIN ; KIM, CHEOL GYEONG ; KIM, HAN GYEONG</creator><creatorcontrib>LEE, GWANG OK ; JUNG, GEUM SIN ; KIM, GI EUN ; LEE, HOE CHEOL ; KIM, MAENG SEOP ; LEE, GWAN SUN ; KIM, HUI SEOK ; HAM, YEONG JIN ; KIM, CHEOL GYEONG ; KIM, HAN GYEONG</creatorcontrib><description>PURPOSE: Provided is a novel manufacturing method of 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1H-imidazol-1-yl))-4H-carbazol-4-on or its pharmaceutically acceptable salt in higher yield and purity than conventional methods. CONSTITUTION: The manufacturing method is characterized by reacting 1,2,3,9-tetrahydro-9-methyl-4H-carbazol-4-on of the formula(2) with 2-methylimidazole derivative of the formula(3) in a mixed solvent of organic solvent and water at room temperature to 150 deg.C fro 2-12 hours to manufacture 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1H-imidazol-1-yl))-4H-carbazol-4-on of the formula(1) or its pharmaceutically acceptable salt. 본 발명은 할로실란 화합물 존재하에서 하기 화학식 2의 1,2,3,9-테트라히드로-9-메틸-4H-카바졸-4-온을 화학식 3의 2-메틸이미다졸 유도체와 유기용매 또는 유기용매와 물의 혼합용매 중에서 반응시키는 것을 특징으로 하는, 화학식 1의 1,2,3,9-테트라히드로-9-메틸-3-[(2-메틸-1H-이미다졸-1-일)메틸]-4H-카바졸-4-온 또는 그의 약제학적으로 허용가능한 염의 제조 방법에 관한 것으로, 본 발명의 방법에 따르면 보다 간단한 공정으로 목적 화합물을 고수율, 고순도로 제조할 수 있다. 상기 식에서, R은 N,N-디메틸아미노, N,N-디에틸아미노, N,N-디프로필아미노, 몰포린-4-일, 피페리딘-1-일 또는 피롤리딘-1-일이다.</description><edition>7</edition><language>eng ; kor</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; METALLURGY ; ORGANIC CHEMISTRY</subject><creationdate>2002</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20020525&amp;DB=EPODOC&amp;CC=KR&amp;NR=20020039223A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20020525&amp;DB=EPODOC&amp;CC=KR&amp;NR=20020039223A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>LEE, GWANG OK</creatorcontrib><creatorcontrib>JUNG, GEUM SIN</creatorcontrib><creatorcontrib>KIM, GI EUN</creatorcontrib><creatorcontrib>LEE, HOE CHEOL</creatorcontrib><creatorcontrib>KIM, MAENG SEOP</creatorcontrib><creatorcontrib>LEE, GWAN SUN</creatorcontrib><creatorcontrib>KIM, HUI SEOK</creatorcontrib><creatorcontrib>HAM, YEONG JIN</creatorcontrib><creatorcontrib>KIM, CHEOL GYEONG</creatorcontrib><creatorcontrib>KIM, HAN GYEONG</creatorcontrib><title>1239--9--3-[2--1--1-]-4--4- PROCESS FOR THE PREPARATION OF 1239-TETRAHYDRO-9-METHYL-3-[2-METHYL-1H-IMIDAZOL-1-YLMETHYL]-4H-CARBAZOL-4-ONE OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF</title><description>PURPOSE: Provided is a novel manufacturing method of 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1H-imidazol-1-yl))-4H-carbazol-4-on or its pharmaceutically acceptable salt in higher yield and purity than conventional methods. CONSTITUTION: The manufacturing method is characterized by reacting 1,2,3,9-tetrahydro-9-methyl-4H-carbazol-4-on of the formula(2) with 2-methylimidazole derivative of the formula(3) in a mixed solvent of organic solvent and water at room temperature to 150 deg.C fro 2-12 hours to manufacture 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1H-imidazol-1-yl))-4H-carbazol-4-on of the formula(1) or its pharmaceutically acceptable salt. 본 발명은 할로실란 화합물 존재하에서 하기 화학식 2의 1,2,3,9-테트라히드로-9-메틸-4H-카바졸-4-온을 화학식 3의 2-메틸이미다졸 유도체와 유기용매 또는 유기용매와 물의 혼합용매 중에서 반응시키는 것을 특징으로 하는, 화학식 1의 1,2,3,9-테트라히드로-9-메틸-3-[(2-메틸-1H-이미다졸-1-일)메틸]-4H-카바졸-4-온 또는 그의 약제학적으로 허용가능한 염의 제조 방법에 관한 것으로, 본 발명의 방법에 따르면 보다 간단한 공정으로 목적 화합물을 고수율, 고순도로 제조할 수 있다. 상기 식에서, R은 N,N-디메틸아미노, N,N-디에틸아미노, N,N-디프로필아미노, 몰포린-4-일, 피페리딘-1-일 또는 피롤리딘-1-일이다.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2002</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjk0KwkAMhbtxIeodBlwH7Iwbl3GaMsWpU9K4qCJSZFyJCno2z-f4cwDhg7yE5L0Ms2euzQIgYWCnAfI3e5hDQjUcLLWtKgMrcZR6apBRqrBWoVSfUyFhdF3BIZnUJK7zX6ufzh1UdVXgNiQNnf-OU4IDi7z8zOcQ1qRSSOOQa7S0kcqi951Ca6kRXHpSLXpp328whXKcDU79-R4nvzrKpiWJdRBv10O83_pjvMTHYcV6NkuYhdYGzX9bL1VGSTA</recordid><startdate>20020525</startdate><enddate>20020525</enddate><creator>LEE, GWANG OK</creator><creator>JUNG, GEUM SIN</creator><creator>KIM, GI EUN</creator><creator>LEE, HOE CHEOL</creator><creator>KIM, MAENG SEOP</creator><creator>LEE, GWAN SUN</creator><creator>KIM, HUI SEOK</creator><creator>HAM, YEONG JIN</creator><creator>KIM, CHEOL GYEONG</creator><creator>KIM, HAN GYEONG</creator><scope>EVB</scope></search><sort><creationdate>20020525</creationdate><title>1239--9--3-[2--1--1-]-4--4- PROCESS FOR THE PREPARATION OF 1239-TETRAHYDRO-9-METHYL-3-[2-METHYL-1H-IMIDAZOL-1-YLMETHYL]-4H-CARBAZOL-4-ONE OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF</title><author>LEE, GWANG OK ; JUNG, GEUM SIN ; KIM, GI EUN ; LEE, HOE CHEOL ; KIM, MAENG SEOP ; LEE, GWAN SUN ; KIM, HUI SEOK ; HAM, YEONG JIN ; KIM, CHEOL GYEONG ; KIM, HAN GYEONG</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_KR20020039223A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; kor</language><creationdate>2002</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><toplevel>online_resources</toplevel><creatorcontrib>LEE, GWANG OK</creatorcontrib><creatorcontrib>JUNG, GEUM SIN</creatorcontrib><creatorcontrib>KIM, GI EUN</creatorcontrib><creatorcontrib>LEE, HOE CHEOL</creatorcontrib><creatorcontrib>KIM, MAENG SEOP</creatorcontrib><creatorcontrib>LEE, GWAN SUN</creatorcontrib><creatorcontrib>KIM, HUI SEOK</creatorcontrib><creatorcontrib>HAM, YEONG JIN</creatorcontrib><creatorcontrib>KIM, CHEOL GYEONG</creatorcontrib><creatorcontrib>KIM, HAN GYEONG</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>LEE, GWANG OK</au><au>JUNG, GEUM SIN</au><au>KIM, GI EUN</au><au>LEE, HOE CHEOL</au><au>KIM, MAENG SEOP</au><au>LEE, GWAN SUN</au><au>KIM, HUI SEOK</au><au>HAM, YEONG JIN</au><au>KIM, CHEOL GYEONG</au><au>KIM, HAN GYEONG</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>1239--9--3-[2--1--1-]-4--4- PROCESS FOR THE PREPARATION OF 1239-TETRAHYDRO-9-METHYL-3-[2-METHYL-1H-IMIDAZOL-1-YLMETHYL]-4H-CARBAZOL-4-ONE OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF</title><date>2002-05-25</date><risdate>2002</risdate><abstract>PURPOSE: Provided is a novel manufacturing method of 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1H-imidazol-1-yl))-4H-carbazol-4-on or its pharmaceutically acceptable salt in higher yield and purity than conventional methods. CONSTITUTION: The manufacturing method is characterized by reacting 1,2,3,9-tetrahydro-9-methyl-4H-carbazol-4-on of the formula(2) with 2-methylimidazole derivative of the formula(3) in a mixed solvent of organic solvent and water at room temperature to 150 deg.C fro 2-12 hours to manufacture 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1H-imidazol-1-yl))-4H-carbazol-4-on of the formula(1) or its pharmaceutically acceptable salt. 본 발명은 할로실란 화합물 존재하에서 하기 화학식 2의 1,2,3,9-테트라히드로-9-메틸-4H-카바졸-4-온을 화학식 3의 2-메틸이미다졸 유도체와 유기용매 또는 유기용매와 물의 혼합용매 중에서 반응시키는 것을 특징으로 하는, 화학식 1의 1,2,3,9-테트라히드로-9-메틸-3-[(2-메틸-1H-이미다졸-1-일)메틸]-4H-카바졸-4-온 또는 그의 약제학적으로 허용가능한 염의 제조 방법에 관한 것으로, 본 발명의 방법에 따르면 보다 간단한 공정으로 목적 화합물을 고수율, 고순도로 제조할 수 있다. 상기 식에서, R은 N,N-디메틸아미노, N,N-디에틸아미노, N,N-디프로필아미노, 몰포린-4-일, 피페리딘-1-일 또는 피롤리딘-1-일이다.</abstract><edition>7</edition><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; kor
recordid cdi_epo_espacenet_KR20020039223A
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
title 1239--9--3-[2--1--1-]-4--4- PROCESS FOR THE PREPARATION OF 1239-TETRAHYDRO-9-METHYL-3-[2-METHYL-1H-IMIDAZOL-1-YLMETHYL]-4H-CARBAZOL-4-ONE OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T08%3A50%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=LEE,%20GWANG%20OK&rft.date=2002-05-25&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EKR20020039223A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true